The Cardiac Home Ambulatory Monitoring Project (CHAMP) was a randomized control trial of the home monitoring of patients with congestive heart failure (CHF) after their discharge from hospital following an acute cardio-respiratory episode. The study’s primary aim was to see if more intensive, cost-effective monitoring at home could lower readmission rates and improve patient outcomes, functional status, and the cost-effectiveness of the cardio-respiratory program.
The study group received the standard care in addition to being educated about the symptoms of CHF, medication, exercise, and nutrition. Participants were given a “Life Signs System”« monitoring technology that could record and transmit vital signs via the telephone to a central repository where it could be reviewed by project staff registered nurses. Results showed the study group had statistically significant higher health satisfaction scores and that telephone consultation averted 32 per cent of emergency visits in the study group. The rate of readmission was 4 per cent in both groups, but the clinic reported that by monitoring the patients at home, it could increase its volume of patients assessed each week from 50 to 82.
This project was supported by the Health Transition Fund, which was created in 1997 to provide support for evidence-based decision-making in health care reform by supporting pilot and evaluation projects which test innovative approaches to health care delivery. The views expressed herein do no necessarily represent the official policy of federal, provincial, or territorial governments.